Colorectal cancer is the second-leading cause of cancer-related death in the U.S., even though it is highly treatable if caught early.2 The American Cancer Society estimates that more than 150,000 ...
Active-duty service members and eligible family members now have access to blood test for colorectal cancer screening with no copay Shield is the first and only blood test approved by the FDA as a ...
PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, today announced new real-world data published in Current Medical Research and Opinion finding ...
Guardant Health says it is the first blood test approved by the FDA as a primary screening option for colorectal cancer. Shield is also the first blood test for colorectal cancer screening that meets ...
Add Yahoo as a preferred source to see more of our stories on Google. SHREVEPORT La. (KTAL/KMSS) – Active duty service members and their families in Louisiana now have access to Guardant Health’s ...
Patrick Dempsey, actor and cancer advocate, shares his experience getting screened for colorectal cancer with Shield by ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening (CRC) is now covered for active-duty service members and ...
In the analysis looking at the initial implementation of a blood-based CRC screening test, Shield yielded an adherence rate of 95%. In the first 20,000 patients with a Shield clinical order placed ...
Active-duty service members and eligible family members now have access to blood test for colorectal cancer screening with no copay Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results